Obligatory and facilitative allelic variation in the DNA methylome within common disease-associated loci

0301 basic medicine 570 Genome, Human Science Q 610 Genetic Variation High-Throughput Nucleotide Sequencing DNA Methylation Polymorphism, Single Nucleotide Article Epigenesis, Genetic 03 medical and health sciences Haplotypes Risk Factors MD Multidisciplinary Humans CpG Islands Disease Genetic Predisposition to Disease Alleles Genome-Wide Association Study
DOI: 10.1038/s41467-017-01586-1 Publication Date: 2017-12-27T11:38:31Z
ABSTRACT
AbstractIntegrating epigenetic data with genome-wide association study (GWAS) results can reveal disease mechanisms. The genome sequence itself also shapes the epigenome, with CpG density and transcription factor binding sites (TFBSs) strongly encoding the DNA methylome. Therefore, genetic polymorphism impacts on the observed epigenome. Furthermore, large genetic variants alter epigenetic signal dosage. Here, we identify DNA methylation variability between GWAS-SNP risk and non-risk haplotypes. In three subsets comprising 3128 MeDIP-seq peripheral-blood DNA methylomes, we find 7173 consistent and functionally enriched Differentially Methylated Regions. 36.8% can be attributed to common non-SNP genetic variants. CpG-SNPs, as well as facilitative TFBS-motifs, are also enriched. Highlighting their functional potential, CpG-SNPs strongly associate with allele-specific DNase-I hypersensitivity sites. Our results demonstrate strong DNA methylation allelic differences driven by obligatory or facilitative genetic effects, with potential direct or regional disease-related repercussions. These allelic variations require disentangling from pure tissue-specific modifications, may influence array studies, and imply underestimated population variability in current reference epigenomes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (100)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....